View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Malvern Panalytical
4 February 2020

NETZSCH Analysing and Testing to Enhance Product Portfolio with Rheometers

NETZSCH proudly announces the extension of its product range with the Kinexus rotational rheometers and Rosand capillary rheometers, previously developed and distributed by Malvern Panalytical.

NETZSCH and Malvern Panalytical look back on many years of close collaboration, making the acquisition of the Malvern Panalytical’s rheology business a natural step in this journey.

For NETZSCH Analyzing & Testing, the acquisition of the two rheometer product families is an extension to the existing product portfolio and an excellent addition to the established thermal analysis instruments. Rotational rheometers help maintain parameters such as consistency and fluidity, which in turn allow predictions to be made about stability, texture, and shelf life. Capillary rheometers enable the optimization of process conditions and material properties for critical product functionality.

This addition to our portfolio will drive significant value to our customers and our business by providing comprehensive product and application services. The inclusion of rheometers in our portfolio will strengthen our ability to provide world-leading scientific instrumentation that delivers unrivalled insight into your material properties.

We will continue the manufacturing of all instruments as well as worldwide sales and support of the two rheometer product families. Of course, we are committed to fulfilling all existing contracts with Kinexus and Rosand rheometer users, including the full-service range, applications, existing contract offerings and spare parts availability as you have come to expect from Malvern Panalytical. During the transition period, Malvern Panalytical Ltd will provide support to NETZSCH so that the transition will be as smooth as possible for our customers.

For more information, please fill out the enquiry form attached to this page.

The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued...
The age of the battery is well underway. Lithium-ion batteries, for example, have already revolutionized our day-to-day lives – from smart mobile devices to pollution-free...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena